Alphabet Inc.
Search results
We are not a traditional biotechnology company, nor are we an academic institution. We have combined the best parts of both without the constraints of either. We are asking difficult questions about how we age and the diseases associated with the aging process.
We are deliberate about creating a community in which Calico scientists and engineers have the freedom to explore, take chances and follow their own scientific pursuits and passions, wherever they may lead.
Calico (Calico Life Sciences LLC) is an Alphabet-founded research and development company whose mission is to harness advanced technologies and model systems to increase our understanding of the biology that controls human aging.
At Calico, our technology labs work hand-in-hand with scientists throughout the company, advancing hypotheses on how specific technologies and know-how can help answer a research question or advance a clinical study at the depth required to progress the field.
Our major partnership with the pharmaceutical company AbbVie provides us with additional research insights and capabilities, and also with the scale and scope necessary to bring a new medicine to patients while maintaining our focus on target discovery and early-stage clinical development.
Calico employees are asking big questions about aging and age-related diseases. Life at Calico provides employees with the freedom and support to answer them, and then pursue their science all the way to the clinic.
In September 2013, Art was named chief executive officer of Calico. Before that, he was chief executive officer of Genentech from July 1995 to April 2009. He currently serves as the chairman of the board of Apple, and previously served as a director of Google from 2004 to 2009.
Why collaborate with Calico . Calico combines the focus and drive of a start-up with the resources and world class R&D capabilities of the leading biotechnology companies.
Calico is currently seeking exceptional candidates who share our passion for understanding the science of aging and developing therapeutics to address age-related diseases. Explore Careers About Us
Calico scientists and collaborators regularly publish in high quality publications to inform the scientific community of discoveries from Calico labs and our collaborators.
